Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2019

01-04-2019

Individual differences of plasma proteins and factors in fresh frozen plasma from Chinese regional blood donors

Authors: Liguo Zhu, Changqing Li, Deqing Wang

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2019

Login to get access

Abstract

Currently, single fresh frozen plasma (FFP) for clinical use is derived from individual blood donors. The objective of this study is to investigate the differences in single FFP units to make related strategies for improving FFP transfusion efficacy. 120 units of single FFP were selected randomly from Chinese PLA Clinical Blood Transfusion Center in Beijing, China. Single FFP samples were thawed in 37 °C water bath and were assessed immediately for total protein (TP), albumin (Alb), fibrinogen (Fg), factor V (FV), factor VIII (FVIII), antithrombin-III (AT-III) and protein C (PC). Multiple comparisons were employed to analysis the differences. The quality levels of 120 single FFP units showed wider ranges and presented normal distribution. Fg, FV and PC showed larger fluctuation range but TP, Alb, FVIII and AT-III showed smaller. The mean level of TP was 56.07 g/L and FVIII was 0.62 IU/mL. There were no significant differences to genders in single FFP units. FFP from younger people with 18–30 years old showed a trend towards reduced activity of coagulation factors, especially FV and FVIII. TP and Alb levels in FFP with type O were significantly higher than that in non-O type, but FVIII, AT-III and PC levels were lower in type O than that in non-O type. In a word, the whole quality of single FFP units from Chinese regional donors was acceptable, except FVIII. There were great differences of plasma proteins and factors in single FFP units, age and ABO blood type were main influence factors.
Literature
1.
go back to reference O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM (2004) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126(1):11–28CrossRefPubMed O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM (2004) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126(1):11–28CrossRefPubMed
2.
go back to reference Puetz J (2013) Fresh frozen plasma: the most commonly prescribed hemostatic agent. J Thromb Haemost 11(10):1794–1799PubMed Puetz J (2013) Fresh frozen plasma: the most commonly prescribed hemostatic agent. J Thromb Haemost 11(10):1794–1799PubMed
3.
go back to reference National Health and Family Planning Commission of the People’s Republic of China (2000) The Technical Criterion of Clinical Blood Transfusion National Health and Family Planning Commission of the People’s Republic of China (2000) The Technical Criterion of Clinical Blood Transfusion
4.
go back to reference European Parliament. Commission directive 2004/33/EC. Official Journal of the European Union 2004, 2004 European Parliament. Commission directive 2004/33/EC. Official Journal of the European Union 2004, 2004
5.
go back to reference National Health and Family Planning Commission of the People’s Republic of China (2012) Quality requirements for whole blood and blood components National Health and Family Planning Commission of the People’s Republic of China (2012) Quality requirements for whole blood and blood components
6.
go back to reference Madla W, Alt T, Jungk H, Bux J (2012) Fresh frozen plasma quality: relation to age and gender of blood donors. Vox Sang 102(2):116–124CrossRefPubMed Madla W, Alt T, Jungk H, Bux J (2012) Fresh frozen plasma quality: relation to age and gender of blood donors. Vox Sang 102(2):116–124CrossRefPubMed
7.
go back to reference Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, van de Loo J (1985) Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population—II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 54(3):721–723CrossRefPubMed Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, van de Loo J (1985) Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population—II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 54(3):721–723CrossRefPubMed
8.
go back to reference Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J (1985) Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 54(2):475–479PubMed Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J (1985) Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 54(2):475–479PubMed
9.
go back to reference Folsom AR, Conlan MG, Davis CE, Wu KK (1992) Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 2(4):481–494CrossRefPubMed Folsom AR, Conlan MG, Davis CE, Wu KK (1992) Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 2(4):481–494CrossRefPubMed
10.
go back to reference Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 97(4):775–784CrossRefPubMed Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 97(4):775–784CrossRefPubMed
11.
12.
go back to reference Wang Z, Liu H, Dou M, Du X, Hu J, Su N, Wang Y, Zhang R, Li C.The quality changes in fresh frozen plasma of the blood donors at high altitude. PLoS ONE 2017 12(4):e0176390 Wang Z, Liu H, Dou M, Du X, Hu J, Su N, Wang Y, Zhang R, Li C.The quality changes in fresh frozen plasma of the blood donors at high altitude. PLoS ONE 2017 12(4):e0176390
13.
go back to reference Wang ZK, Dou MM, Du X, Ma L, Sun P, Cao HJ et al (2017) Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population. PeerJ 5:e3156CrossRefPubMedPubMedCentral Wang ZK, Dou MM, Du X, Ma L, Sun P, Cao HJ et al (2017) Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population. PeerJ 5:e3156CrossRefPubMedPubMedCentral
14.
go back to reference Favaloro EJ, Soltani S, Mc Donald J, Grezchnik E, Easton L, Favaloro JW (2005) Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder. Am J Clin Pathol 124(6):910–917CrossRefPubMed Favaloro EJ, Soltani S, Mc Donald J, Grezchnik E, Easton L, Favaloro JW (2005) Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder. Am J Clin Pathol 124(6):910–917CrossRefPubMed
15.
go back to reference Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA (1999) Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999 82(5):1456–1461CrossRefPubMed Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA (1999) Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999 82(5):1456–1461CrossRefPubMed
17.
go back to reference Albánez S, Ogiwara K, Michels A, Hopman W, Grabell J, James P, Lillicrap D (2016) Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. J Thromb Haemost 14(5):953–963CrossRefPubMedPubMedCentral Albánez S, Ogiwara K, Michels A, Hopman W, Grabell J, James P, Lillicrap D (2016) Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. J Thromb Haemost 14(5):953–963CrossRefPubMedPubMedCentral
18.
go back to reference Rios DRA, Fernandes AP, Figueiredo RC, Guimaraes DAM, Ferreira CN, Silva E, Carvalho ACS, Gomes MG, Dusse KB (2012) LMS. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis. J Thromb Thrombolysis 33:416–421CrossRefPubMed Rios DRA, Fernandes AP, Figueiredo RC, Guimaraes DAM, Ferreira CN, Silva E, Carvalho ACS, Gomes MG, Dusse KB (2012) LMS. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis. J Thromb Thrombolysis 33:416–421CrossRefPubMed
19.
go back to reference Solheim BG, Chetty R, Flesland O (2008) Indications for use and cost-effectiveness of pathogen-reduced ABO-universal plasma. Curr Opin Hematol 15(6):612–617CrossRefPubMed Solheim BG, Chetty R, Flesland O (2008) Indications for use and cost-effectiveness of pathogen-reduced ABO-universal plasma. Curr Opin Hematol 15(6):612–617CrossRefPubMed
20.
go back to reference Heger A, Brandstätter H, Prager B, Brainovic J, Cortes R, Römisch J (2015) Universal pooled plasma (Uniplas(®)) does not induce complement-mediated hemolysis of human red blood cells in vitro. Transfus Apher Sci 52(1):128–135CrossRefPubMed Heger A, Brandstätter H, Prager B, Brainovic J, Cortes R, Römisch J (2015) Universal pooled plasma (Uniplas(®)) does not induce complement-mediated hemolysis of human red blood cells in vitro. Transfus Apher Sci 52(1):128–135CrossRefPubMed
21.
go back to reference Wang S, Zhou W, Zhuang Y, Zhang D, Li H, Wang D (2012) Study on preparation of universal plasma in Chinese Han population. Transfus Apher Sci 47(2):167–170CrossRefPubMed Wang S, Zhou W, Zhuang Y, Zhang D, Li H, Wang D (2012) Study on preparation of universal plasma in Chinese Han population. Transfus Apher Sci 47(2):167–170CrossRefPubMed
Metadata
Title
Individual differences of plasma proteins and factors in fresh frozen plasma from Chinese regional blood donors
Authors
Liguo Zhu
Changqing Li
Deqing Wang
Publication date
01-04-2019
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2019
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1789-9

Other articles of this Issue 3/2019

Journal of Thrombosis and Thrombolysis 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.